Aims and Scope of Journal of Antimicrobial Chemotherapy
The Journal of Antimicrobial Chemotherapy is a peer-reviewed medical journal which covers antimicrobial chemotherapy, including laboratory aspects and clinical use of antimicrobial agents. It is published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy and was established in 1975. In January 2015 J. Peter Donnelly (Radboud University Nijmegen Medical Centre) became the eighth editor-in-chief replacing Alan P. Johnson (Health Protection Agency, London, United Kingdom). The journal has had two previous publishers. All content is available for free after 12 months while authors also have the option to have their articles published immediately as open access. Less
Key Metrics
CiteScore 

9.4
H-Index 

211
Impact Factor 

5 - 10
Scite Index 

0.86 5-Year SI

SJR 

Q1Pharmacology

SNIP 

1.65
Recommended pre-submission checks
Powered by 

Topics Covered on Journal of Antimicrobial Chemotherapy
Journal of Antimicrobial Chemotherapy Journal Specifications
| Overview | |
| Publisher | OXFORD UNIV PRESS |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1975 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Journal of Antimicrobial Chemotherapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Journal of Antimicrobial Chemotherapy
Genome-wide network of antibiotic susceptibility in Pseudomonas aeruginosa
- 5 Aug 2026
- Journal of Antimicrobial Chemotherapy
Cerebral aspergillosis under ibrutinib therapy: clinical features and management challenges.
- 4 Aug 2026
- The Journal of antimicrobial chemotherapy
Evaluating the efficiency of platform trials relative to stand-alone trials: a simulation study for the evaluation of new antibacterials
- 4 Aug 2026
- Journal of Antimicrobial Chemotherapy
Antimicrobial resistance in Neisseria gonorrhoeae isolates at the Bangrak STIs Center, Bangkok, Thailand and WGS of antimicrobial-resistant isolates, 2018\u201323
- 4 Aug 2026
- Journal of Antimicrobial Chemotherapy
Clinical characteristics and outcomes of patients with bacteraemia caused by non-carbapenemase-producing, carbapenem-resistant Enterobacterales.
- 4 Aug 2026
- The Journal of antimicrobial chemotherapy
Treatment of acyclovir-resistant varicella-zoster virus keratitis with amenamevir in an immunocompromised patient.
- 4 Aug 2026
- The Journal of antimicrobial chemotherapy
Genome-wide network of antibiotic susceptibility in Pseudomonas aeruginosa
- 5 Aug 2026
- Journal of Antimicrobial Chemotherapy
Cerebral aspergillosis under ibrutinib therapy: clinical features and management challenges.
- 4 Aug 2026
- The Journal of antimicrobial chemotherapy
Evaluating the efficiency of platform trials relative to stand-alone trials: a simulation study for the evaluation of new antibacterials
- 4 Aug 2026
- Journal of Antimicrobial Chemotherapy
Antimicrobial resistance in Neisseria gonorrhoeae isolates at the Bangrak STIs Center, Bangkok, Thailand and WGS of antimicrobial-resistant isolates, 2018\u201323
- 4 Aug 2026
- Journal of Antimicrobial Chemotherapy
Clinical characteristics and outcomes of patients with bacteraemia caused by non-carbapenemase-producing, carbapenem-resistant Enterobacterales.
- 4 Aug 2026
- The Journal of antimicrobial chemotherapy
Treatment of acyclovir-resistant varicella-zoster virus keratitis with amenamevir in an immunocompromised patient.
- 4 Aug 2026
- The Journal of antimicrobial chemotherapy